FIELD: medicine.
SUBSTANCE: main indicators are determined initially: histology of tumour formation - oligodendroglioma, oligoastrocytoma, astrocytoma, patient's age, tumour stage (T1-T3). Then the additional indicators are determined - Karnofsky index level and presence of episyndrome. Considering the obtained data of Table 1 "predictive model" contained in the description, a prognostic group number from 1 to 5 is defined. The higher the group number, the worth is the prediction.
EFFECT: method allows accessible and informative allocation of prognostic groups and determination of tumour formation progress prediction by evaluating the most significant main and additional indicators.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYPERTHERMIC ELECTROTHERAPY (ONCOTHERMIA) IN COMBINED AND COMPLEX TREATMENT OF HIGH-GRADE GLIOMAS | 2017 |
|
RU2692985C2 |
| METHOD FOR DETERMINING A SURVIVAL PREDICTION OF PATIENTS WITH BRAIN GLIOMAS GRADE 2-GRADE 4 | 2019 |
|
RU2740481C2 |
| PREDICTION OF EFFICIENCY OF USING RADIATION THERAPY | 2020 |
|
RU2780780C2 |
| METHOD OF TREATING GLIAL BRAIN TUMOURS OF SUPRATENTORIAL LOCALISATION | 2013 |
|
RU2551241C2 |
| METHOD FOR PREDICTION OF EVOLUTION OF CEREBRAL GLIOMAS | 2020 |
|
RU2740194C1 |
| METHOD FOR OBTAINING AN ORTHOTOPIC PDX MODEL OF HUMAN BRAIN GLIOBLASTOMA ON IMMUNODEFICIENT MICE FOR PRECLINICAL STUDY OF ANTITUMOR EFFECTS OF CYTOSTATIC DRUGS | 2021 |
|
RU2761892C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HIGH GRADE GLIOMAS | 2022 |
|
RU2786003C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRIMARY AND SECONDARY MALIGNANT BRAIN TUMORS | 2016 |
|
RU2628816C1 |
| METHOD FOR PREDICTING THE COURSE OF LOW-DIFFERENTIATED GLIAL TUMORS BASED ON A CYTOKINE MICROENVIRONMENT | 2020 |
|
RU2741690C1 |
| METHOD OF TREATMENT OF MALIGNANT BRAIN GLIOMAS | 2020 |
|
RU2746903C1 |
